Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M
Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.
Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models
Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data.
Medtronic adds new AI models to its insertable cardiac monitors
The new algorithms are automatically applied in the cloud; patients wearing the devices are not required to take any additional steps.
World’s first dual-chamber leadless pacemaker still going strong after 6 months
Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.
HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston.

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

August 28, 2018

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

May 14, 2018

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

May 11, 2018

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

March 19, 2018

Electrophysiology pioneer Arthur J. Moss dies at 86

Arthur J. Moss, MD, known in the cardiology field for his extensive research in diagnosing and treating long QT syndrome (LQTS), died of cancer Feb. 14 at his home in Brighton, New York. He was 86.

March 1, 2018

HRS2017: Wearable defibrillators are safe, effective for pediatric patients

A new study from Cincinnati’s Children’s Hospital has found that the use of a wearable cardioverter defibrillator (WCD) is safe and effective for treating ventricular arrhythmias in pediatric patients at risk from sudden cardiac death.

May 15, 2017

HRS2017: AI-enabled Apple Watch detects AFib in UCSF study

Apple devices just keep getting smarter. New research presented at this year’s Heart Rhythm Society (HRS) conference in Chicago showed that when paired with an artificial intelligence-based algorithm, the watch can detect atrial fibrillation (AFib).

May 15, 2017

Boston Scientific Announces Positive European Registry Results For WATCHMAN Left Atrial Appendage Closure Device

MARLBOROUGH, Mass., May 12, 2017 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a late-breaking clinical trial session at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions in Chicago. Data confirmed that the WATCHMAN device had a high implant success rate and was effective in stroke reduction for patients with non-valvular atrial fibrillation (AF), including those patients deemed unsuitable for oral anticoagulation.

May 12, 2017

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Electrophysiology

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

Medtronic adds new AI models to its insertable cardiac monitors

World’s first dual-chamber leadless pacemaker still going strong after 6 months

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

Around the web